Biolog Recently Wins $2M in NIH Grants; Firm to Further Develop Phenotype Microrrary

Biolog has pocked approximately $2 million through four recent grants from the US National Institutes of Health, according to the NIH.

The company is developing living mammalian cell arrays for drug-discovery and -development applications. The four new grants, which the NIH said are effective as of Dec. 26, include:

• $920,940 for the detection of bioterrorism agents with [the company’s phenotype microarray] technology;

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.